top of page

The RhAPP 2024 Regional Summit Series: Guidelines and Beyond will be an educational series focusing on hot topics in psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), gout, and vasculitis. 

Regional Chapter:

Mid Atlantic

New York, NY

Regional Chapter:


Chicago, IL

Regional Chapter:


Denver, CO

Regional Chapter:


Columbus, OH

Regional Chapter:


Atlanta, GA

Regional Chapter:


Phoenix, AZ

Regional Chapter:


San Antonio, TX

Regional Chapter:


Southern Florida


Target Audience

This activity has been designed to meet the educational needs of APPs (nurses, NPs, PAs) and PharmDs involved in the care of patients with rheumatic disease and who may be unable to attend the annual RhAPP National Conference.

Program Overview

The joint providership of Medical Education Resources (MER) and Rheumatology Advanced Practice Providers (RhAPP) presents the 2024 RhAPP Regional Summit Series. Each summit will feature an educational program focused on hot topics in psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), gout, and vasculitis.

Educational Objectives

After completing this activity, participants should be better able to:

  • Describe the latest clinical guidelines and treatment recommendations for the management of rheumatic disease.

  • Individualize treatment and dosing for patients with rheumatic disease by assessing the latest evidence-based benefits of the available treatments.

  • Assess the risk factors associated with each treatment recommendation and carefully monitor patients for adverse events.

  • Evaluate new treatment options for rheumatic disease and therapeutics development.

  • Assess the risk-benefit for patients receiving new therapeutics for rheumatic disease.


Accreditation Statements:

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Rheumatology Advance Practice Providers (RhAPP). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medical Education Resources has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


Medical Education Resources (MER) designates this continuing education activity for 1.75 contact hours (0.175 CEUs) of the Accreditation Council for Pharmacy Education. UAN JA0003680-9999-24-160-L01-P.


This activity is certified as a knowledge-based CPE.

Medical Education Resources designates this live activity for a maximum of 1.75 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.


MER and Rheumatology Advance Practice Providers planners have no relevant financial relationships to disclose.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Rheumatology Advance Practice Providers, and/or Amgen, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Fee Information

There is no fee for this educational activity.

Special Requests

Special request info - AMERICANS WITH DISABILITIES ACT: The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at

Jointly provided by the Medical Education Resources and Rheumatology Advanced Practice Providers (RhAPP).

RhAPP Social.png

Supported by educational grants from Amgen and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.


Industry-employed healthcare providers are not permitted to register unless sponsoring the meeting. Registrants must be active advanced practice providers in a community or academic setting.
If interested in sponsoring an event, please contact

Anne Michaels at

Become a RhAPP Member

bottom of page